UTHR FY 2010 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$604M+63.3% YoY

Gross Profit

$530M87.8% margin

Operating Income

$164M27.2% margin

Net Income

$106M17.5% margin

EPS (Diluted)

$1.78

Cash Flow

Operating Cash Flow

$212M

Free Cash Flow

$193M

Stock-Based Comp.

$114M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$548M

Stockholders' Equity

$884M

Cash & Equivalents

$252M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$604M	$370M	+63.3%
Gross Profit	$530M	$325M	+63.4%
Operating Income	$164M	$26M	+530.8%
Net Income	$106M	$19M	+444.2%